Seven Eight Capital’s Array Biopharma Inc ARRY Stock Holding History

Seven Eight Capital’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-211,421	Closed	-$9.79M	–	797
2019 Q2	$9.79M	Buy	+211,421	New	+$5.94M	0.52%	50
2018 Q1	–	Sell	-48,400	Closed	-$620K	–	609
2017 Q4	$620K	Buy	48,400 +37,300	+336%	+$424K	0.06%	303
2017 Q3	$137K	Buy	11,100 +9,400	+553%	+$87.3K	0.02%	425
2017 Q2	$14K	Buy	+1,700	New	+$13.9K	﹤0.01%	520

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Seven Eight Capital's ARRY Position: Q3 2019 in Review

Seven Eight Capital sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 211,421 shares — an estimated $9.79M sold.

Seven Eight Capital first reported a position in ARRY in Q2 2017 and held it in 4 quarters. The position peaked at $9.79M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Seven Eight Capital reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Seven Eight Capital sold 211,421 Array Biopharma Inc shares in Q3 2019, an estimated $9.79M.
Seven Eight Capital first reported a position in Array Biopharma Inc in Q2 2017 and held it in 4 quarters.
Seven Eight Capital's Array Biopharma Inc position peaked at $9.79M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Seven Eight Capital's 13F filing for Q3 2019, filed 14 Nov 2019.